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From May-July 2011, Germany experienced a large Shiga toxin-producing E. 
coli (STEC) O104:H4 outbreak. Our objective was to identify the prevalence of 
STEC O104:H4 carriers in households in highly affected areas, the rate of 
secondary household transmissions, and the duration of long-term shedding. 
 
Methods 
In a cross-sectional study, we recruited case and control households to 
determine STEC household prevalence; we then conducted a prospective 
cohort study (≥2-persons households with ≥1 case) for rates of household 
transmission and shedding duration.   
 
Results 
For part 1, we recruited 57 case households (62 cases and 93 household 
contacts) and 36 control households (89 household members). We only 
detected cases in previously known case households and identified 1 possible 
adult-to-adult household transmission. For part 2, we followed 14 households 
and 20 carriers.  No secondary household transmission was detected in the 
prospective follow-up. The longest prolonged shedding lasted >7 months, 
however, median estimated shedding time was 10-14 days (95% CI: 0-33 




Prevalence of STEC O104:H4 carriers even in highly affected areas appears to 
be low. Despite prolonged shedding in some patients, secondary adult-to-
adult household transmissions seem to be rare events in the post-diarrheal 








From May-July 2011, Germany experienced a large outbreak of Shiga 
toxin-producing Escherichia coli (STEC) O104:H4 associated with fenugreek 
sprouts [1], causing a total of 2,987 gastroenteritis, 855 hemolytic-uremic 
syndrome (HUS) cases and 53 deaths [2]. The outbreak’s epidemic profile that 
significantly differed from previous Escherichia (E.) coli outbreaks and 
notification data can be explained to a great extent by the causing vehicle: 
cases were predominantly adults with a median age of 46 years for 
gastroenteritis and 42 years for HUS; furthermore, cases mostly occurred 
among women (58% and 68%, respectively) [2]. The estimated median 
incubation period was 8 days (IQR: 6-10) [2]. The highest incidence was 
reported for gastroenteritis cases in the district of Herzogtum Lauenburg 
(60.55/100,000 inhabitants) and for HUS cases in the district of Schleswig-
Flensburg (13.1/100,000 inhabitants), both located in the most Northern 
federal state Schleswig-Holstein [2, 3]. 
At initiation of our study, almost no information was available on 
household-level prevalence of STEC O104:H4 carriers and their role in 
secondary transmissions. For E. coli O157, secondary transmissions have been 
reported in association with sporadic cases and may account for up to 20% 
of cases in outbreaks [4-8]. Young age of primary and secondary cases was 
identified as risk factor for secondary transmission [5, 8]. A study by Ludwig et 
al. has shown that asymptomatic E. coli O157 infections in household 
contacts are common and undiagnosed asymptomatic infections may 
contribute to secondary transmission [9]. 
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Knowledge of E. coli carrier prevalence and rates of secondary 
household transmissions is essential for the decision on further short and long-
term containment measures. Starting 3 weeks after the first outbreak 
notification, we conducted an investigation to identify the prevalence of 
STEC O104:H4 carriers in households, the risk for secondary household 
transmission, and the duration of long-term shedding.  
METHODS 
In a cross-sectional study we first screened non-single person households 
with and without reported STEC gastroenteritis or HUS cases for STEC O104:H4 
carriers. Screening of households was performed 3-10 weeks after first 
notification of the outbreak. In the second part, we followed households with 
a carrier in a prospective cohort study to determine rates of secondary 




A case was defined as a notified STEC gastroenteritis or HUS case with 
serogroup O104 or unknown serogroup and onset of disease after April 30, 
2011, residing in the district of Herzogtum Lauenburg or Schleswig-Flensburg, 
or a case with symptomatic or asymptomatic STEC O104:H4 infection 
diagnosed during our investigation by detection of STEC O104:H4 in a stool 
sample. Disease onset was defined as onset of bloody or non-bloody 
diarrhoea, and diarrhoea as ≥2 loose stools within 24 hours. A person with 
detection of STEC O104:H4 after symptomatic or asymptomatic infection was 
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considered a carrier. A secondary household transmission was defined as 
STEC O104:H4 infection with disease onset or STEC O104:H4 detection >10 
days after disease onset in the primary case, referring to the estimated 
incubation period of STEC O104:H4 [2].  A case household was defined as a 
non-single household with ≥1 reported STEC gastroenteritis or HUS case; a 
control household as a non-single household without a notified STEC 
gastroenteritis or HUS case.  
 
Study design 
The screening of case households and the prospective cohort study 
were conducted in the districts of Herzogtum Lauenburg and Schleswig-
Flensburg, whereas screening of control households was only performed in 
Herzogtum Lauenburg. We recruited 52 and 40 case households based on 
mandatory notification to the public health authorities of Herzogtum 
Lauenburg and Schleswig-Flensburg, respectively. In Herzogtum Lauenburg, 
52 control households were randomly selected by recruiting a household in 
direct neighbourhood of the case household. In Herzogtum Lauenburg, 
households were contacted face-to-face, whereas in Schleswig-Flensburg 
study materials were mailed after phone contact. 
For screening, all participants were asked to provide a stool sample and 
answer a questionnaire collecting information on demographic data, 
symptoms, symptom onset, and food items consumed. Household members 
of cases were asked about symptoms in the period between 14 days prior to 
disease onset of index case and time of screening, participants of control 
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households about symptoms in the 14 days prior to screening. Instructions on 
stool sampling and information on basic infection control/hygiene 
precautions to prevent secondary transmission were provided orally by public 
health authorities once and in printed format enclosed for each stool 
sampling.  
Households with ≥1 carrier and ≥1 household member without reported 
STEC  gastroenteritis or HUS prior to and at time of screening were enrolled in 
the prospective cohort study. All participants were asked to provide stool 
samples and information on gastrointestinal symptoms since last stool 
sampling on a 14 days interval. At first follow-up, the questionnaire also 
contained questions on household and participants characteristics and hand 
hygiene practice. The sampling was continued until all household carriers 
tested negative. A negative test had to be confirmed by 2 additional 
negative samples on 2 consecutive days.  
 
Laboratory investigation 
Stool samples and questionnaires were sent by regular mail to the Robert 
Koch Institute. Upon arrival, samples were transported at 4-8° Celsius to the 
National Reference Centre for Salmonella and other Bacterial Enteric 
Pathogens. Isolation and identification of the outbreak strain were performed 
by culturing a stool sample aliquote for 6-18h in modified Tryptic Soy-
enrichment broth with 10mg/l novobiocin and 6mg/l cefsoludin and 
subsequent plating on extended-spectrum beta-lactamase (ESBL) selective 
agar medium (tryptone bile X-glucuronide-agar containing 1mg/l 
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cefotaxime). Presence of stx2, rfb O104 and fliC H4 genes was determined by 
means of multiplex PCR of single bacterial colonies and is described 
elsewhere [3, 10].  
 
Statistical analysis 
We used Wilcoxon rank sum test for differences between distributions 
and calculated odds ratios for exposure variables. A 5%-significance level was 
used for testing. Duration of shedding was quantified by the survival function, 
which was estimated using nonparametric maximum likelihood for interval-
censored data as follow-up was not from time of diagnosis and performed on 
a 14 days interval for cases tested positive at time of screening [11]. Resulting 
intervals for quantiles of the shedding distribution could then be calculated 
from this curve. Uncertainty in the quantile estimation was quantified by 95%-
confidence intervals (CI) based on percentile bootstrap on 999 re-samples of 
the data.  Further detailed descriptions and examples on the use of interval-
censored data analysis can be found elsewhere [12]. 
Stata® version 11.0, StataCorp, Texas, USA and R version 2.12.0, Vienna, 
Austria applying the R package “interval” was used for statistical analysis [13].  
 
Ethical approval 
In accordance with Article 25 paragraph 1 of the German Infection 
Protection Act of 2001 and in agreement with the responsible ethical review 
board regarding ongoing outbreaks, a formal ethical review process and 
approval was not required. We informally discussed the study design with the 
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ethical review board of the Charité University Medicine, Berlin, Germany, 
charged to oversee compliance with the Declaration of Helsinki, and no 




Response of case and control households was 88% (46/52) and 69% 
(36/52), respectively, in Herzogtum Lauenburg, and 45% (18/40) in case 
households in Schleswig-Flensburg. After excluding 7 case households that 
provided ≤1 stool sample per household, 57 (90%) case households with a 
total of 62 cases and 93 household contacts, and 36 (100%) control 
households with 89 participants met the inclusion criteria. Twenty of 62 (32%) 
cases tested positive for STEC O104:H4 at time of screening. Median time 
between disease onset and stool sampling was 26 days (range 10-53) for 
cases tested positive for STEC O104:H4 in our screening, and 33 days (range 
10-58) for cases tested negative (p=0.21). Median time for stool samples from 
collection to arrival at RKI and the laboratory was 2 (range 1-5) and 3 days 
(range 1-6), respectively, for all participants and did not significantly differ for 
cases with and without STEC O104:H4 detection in our screening (p=0.6 and 
p=0.59, respectively).  
Disease onset of cases occurred between May 9 and June 20. The 
majority of cases were females (34/62; 55%) and ≥18 years of age (61/62; 
98%). Four (6%) of 62 cases were reported as HUS cases. Of the 57 cases with 
available information, 40 (70%) were hospitalized.  
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Symptoms of diarrhoea and bloody diarrhoea were reported for 100% 
(62/62) and 74% (46/62) of cases, respectively. Nine of 93 (10%) case 
household contacts reported diarrhoea ranging from 6 days prior to 4 days 
after disease onset of the index case. Diarrhoea ≤14 days prior to screening 
was stated by 16% (14/89) of participants from control households. None of 
them reported bloody diarrhoea or sprout consumption. Cases were more 
likely to report consumption of sprouts, cucumber, raw tomatoes and lettuce 
than non-cases with the highest odds ratio for sprout consumption (see table).  
 
STEC O104:H4 household prevalence 
All 89 stool samples from control households were tested negative for 
STEC O104:H4. Among case households, 42/62 (68%) cases had negative 
testing results.  
All but one of the 20 positive stool samples could be attributed to previously 
known cases.  
 
Households with multiple cases 
Including the previously undetected case, 5 households had 2 cases per 
household. In 3 households, disease onset for the second case was 1, 5, and 6 
days, respectively, after disease onset of the primary case. In the fourth 
household, disease onset for the symptomatic but previously undiagnosed 
second case was 34 days after disease onset of the primary case. The 
questionnaire and interview exploration of this second case revealed no 
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evidence for late sprout exposure.  There was no information available on 
disease onset of the second household case for the fifth household. 
 
Part 2 
We identified a total of 17 households with ≥1 STEC O104:H4 case still 
positive at time of screening: 14 households with 1 case and 3 households 
with 2 cases. One 2-person household of the 14 households with 1 case had 
to be excluded as both members had been previously reported as cases; in 
addition, 2 of the 3 households with 2 cases had to be excluded for 
household transmission follow-up, as the households solely consisted of the 2 
cases. However, we included them for determination of shedding duration. 
The included 14 households comprised of 4 (29%) 4-persons households, 2 
(14%) 3-persons households, and 8 (57%) 2-persons households.  
The median age of the 15 cases was 48 years (range 20-77) and 47 years 
(range 1-76) for the 21 contacts. Only 1 household member was <6 years. Ten 
(67%) of the cases and 6 (29%) of the contacts were female. Three cases and 
3 contacts reported a chronic disease. 
The 14 households participated with a total of 132 samples during the 
prospective study. Three households were lost to follow-up after 1 prospective 
sampling. For the remaining 11 households, the median time of participation 
per household was 26 days (range 0-237). The median time interval between 
each household sampling was 22 days (range 14-37).  
Thirty (83%) of the 36 participants answered all questions on hand 
hygiene practices. Twenty-six (87%) of these 30 participants reported to 
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“always” or “most of the times” wash their hands when coming home (15 
cases, 11 contacts), 24 (78%) before preparing meals (13 cases, 11 contacts; 6 
do not prepare meals), and all after using the toilet.  Seventeen (57%) 
participants reported to wash their hands more frequently after the STEC 
diagnosis of themselves (n=10) or their family member (n=7), the remaining 13 
did not change behaviour (5 cases, 8 contacts). 
 
Rate of household transmissions 
No household transmissions were detected during the prospective study 
period. 
 
Duration of shedding 
We followed-up 20 carriers that tested positive in our screening. The 
median time interval between each sampling was 19 days (range 14-37). A 
total of 12 carriers sent in 2 final consecutive stool samples with a median of 
21 days (range 16-44) after having tested negative. Two consecutive 
negative stool samples were reported by 4 carriers at their primary care 
physician. One carrier was lost to follow-up; another 3 with negative test result 
withdrew from the study after the first prospective sampling. Three carriers 
showed a period of intermittent shedding. The longest duration of shedding 
was 237 days between disease onset and last positive O104:H4 test result; no 
underlying chronic disease was reported for this case. Details of the follow-up 
are shown in figure 1.  
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Fifty-seven of the 62 (92%) cases that participated in the screening part had a 
reported date of disease onset and could therefore be included in the 
calculation of time intervals in which cases became negative. Figure 2 shows 
the estimated survival curve for interval-censored data. Grey areas of the 
curve show indistinguishable values of the survival function, i.e. the exact 
value is not known, except that the function cannot increase within the 
interval. Estimated median shedding time was 10 to 14 days (95% CI: 0-33), 
with the 75% and 90% quantile being 44 to 45 days (95% CI: 23-70) and 67 to 
70 days (95% CI: 44-123), respectively. For comparison, figure 2 also contains 
Kaplan-Meier estimated survival curves when using either the beginning, 
midpoint or endpoint as imputed event time.  
 
DISCUSSION 
The German STEC O104:H4 outbreak was caused by a previously rarely-
reported strain and resulted in considerable morbidity and mortality [3, 14, 15]. 
Uncertainty was high about the extent of asymptomatic infections, rate of 
person-to-person transmission, long-term carriers in the community and their 
potential public health impact.  
In our investigation, no symptomatic or asymptomatic cases in control 
households were identified, even though we chose the districts with the 
highest incidence of STEC gastroenteritis and HUS cases, respectively. About 
10% of the household contacts reported diarrhoea 0-6 days around disease 
onset in the index case and 16% of the participants of control households 
reported diarrhoea 14 days prior to sampling, but were tested negative in the 
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screening. However, cases could have been missed due to test sensitivity (as 
screening was based on only 1 sampling), short duration of shedding, or 
intermittent shedding, as it has been previously described for E. coli O157 in 
children [16]. To limit the effect of potential recall bias controls were not 
interviewed about symptoms regarding the same time period as cases; 
exposure and illness assessments have therefore limited comparability.  
Descriptions of STEC O104:H4 secondary transmissions have meanwhile 
been published. Hauri et al. described at least 6 possible secondary 
transmissions within 4 families among a total of 179 STEC gastroenteritis or HUS 
cases in the state of Hesse [17]. All primary cases were adults, 1 of the 
secondary cases occurred in a child [17]. Kuijper et al. published 1 case of 
possible secondary transmission in a child from the Netherlands whose mother 
had acquired the infection during a visit to Germany [18]. Finally, 2 more 
cases (involving 1 child) of potential secondary transmission within 1 
household were reported from a STEC O104:H4 outbreak in France [19]. All 
secondary household transmissions occurred early after disease onset of the 
primary case and mainly affected persons taking care of the primary case 
[16] or in children of primary cases [17-19].  
We identified only 1 potential secondary household transmission in the 
screening part of our study and no further secondary transmissions in the 
follow-up. In contrast to other publications, our potential secondary 
transmission occurred late after disease onset of the primary case. 
Furthermore, both cases were adults. For E. coli O157, 2 studies showed that 
the majority of secondary household cases were seen early after disease 
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onset of the primary case, and no secondary cases in household contacts 
occurred when the primary case was an adult [5, 8]. A population-based 
survey in Scotland attributed 9% of all secondary cases to transmission among 
adults [7]. The STEC O104:H4 outbreak predominantly affected the adult 
population which is mirrored by our all-adult cohort apart from one child. 
Hygiene measures are more easily followed by adults, and regular reminders 
on basic infection/hygiene precautions during the prospective follow-up 
could have lowered the risk of household transmissions. Seto et al. showed in 
a model based on an E. coli O157 outbreak in the United States that even a 
modestly effective strategy to interrupt secondary transmission can result in a 
significant reduction of symptomatic cases [4].  
As we could not follow carrier households from disease onset of the 
primary case, and first screening starting with a median of 31 days after 
disease onset, we might have missed secondary cases occurring early during 
disease of the primary case. Patients with STEC O104:H4 from households with 
early primary cases have been sporadically reported through mandatory 
notification after the official end of the outbreak, suggesting late secondary 
transmissions could have occurred.  
We were able to document long-term shedding after STEC O104:H4 
infection for >7 months in one adult carrier without underlying chronic disease 
and could observe a negative test followed by a positive test result in carriers 
what may be attributed to test sensitivity or suggest intermittent shedding. The 
follow-up of carriers starting from time of screening instead of disease onset 
resulted in large CI for estimates of shedding duration and thus the estimated 
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survival function should be interpreted accordingly. However, the estimated 
median duration of shedding in our study is similar to results by Karch et al. in 
children with E. coli O157 [16].  
We did not assess risk factors associated with long-term shedding, as for 
example antibiotic treatment. Yet this information could be relevant for 
containment measures. A study published by Nitschke et al. showed an 
inverse association between macrolide therapy and duration of shedding of 
STEC O104:H4 [20].  
STEC O104:H4 carriers employed in risk areas like food handling and 
medical or institutional settings are excluded from work and have usually to 
provide 3 consecutive negative stool samples before re-admittance to work 
[21]. Yet extended work absences in long-term carriers have not only financial 
implications both for employer and employee. Our findings could contribute 
to the discussion about earlier work re-admittance for some adult long-term 
carriers. However, as STEC O104:H4 can cause severe morbidity and mortality, 
any earlier re-admittance needs to be carefully weighted and further be 
based on a comprehensive individual risk assessment, incorporating other 
individual aspects such as work environment, performed work procedures, 
and adherence to hygiene measures. It has to be noted that undiagnosed 
asymptomatic carriers may pose a higher transmission risk than known long-
term carriers.   
The small sample size of our study and therefore limited power makes 
conclusive statements on STEC O104:H4 carrier prevalence and household 
transmissions difficult. Mainly due to logistic reasons, the aimed for time 
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interval for consecutive sampling was not met. Furthermore, the study 
population was biased towards having knowledge about carrier(s) in the 
household, and it consisted mainly of cases with longer shedding time who 
may have distinguishing characteristics from other cases in the outbreak. 
Response in our study differed between districts that could be due to different 
recruitment methods. In Schleswig-Flensburg, disease severity of cases may 
have resulted in a lower response as this district had the highest reported HUS 
incidence; compared to 25% of cases that developed HUS during the 
outbreak [3], our study population included only 6% HUS cases. Stool sampling 
procedures and transport conditions until arrival at the laboratory may have 
resulted in lower sensitivity. Before screening, information on the serotype was 
not always available. Therefore, cases could have been caused by non-
outbreak serotypes that would not have been detected by our laboratory 
approach. We assume not to have missed a significant number of cases by 
employing the ESBL phenotype to detect the outbreak strain, although 
Aldabe et al. reported the loss of the characteristic ESBL pattern in an 
O104:H4 isolate within a family cluster [19]. The ESBL phenotype appeared 
very stable during the acute outbreak, as none of the >300 STEC isolates 
detected by routine diagnostic methods, i. e. without ESBL phenotype 
selection during the acute outbreak was of serotype O104:H4 (unpublished 
data, National Reference Centre for Salmonella and other Bacterial Enteric 
Pathogens). 
Several questions of public health and clinical relevance that arise in the 
context of long-term shedding need to be addressed in further studies such as 
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the potential of STEC O104:H4 to become endemic, identification of risk 
factors for long-term shedding,  association between long-term shedding, co-
morbidities and concomitant medical interventions, potential risks and 
benefits of antibiotic eradication in carriers, stability of the ESBL phenotype of 
the outbreak strain, and possible ESBL plasmid transfer and its significance on 
individual and population level. In addition, seroprevalence studies could 
possibly give important insights to estimate the proportion of asymptomatic 
infections. Finally, further studies are needed to assess the risk of secondary 
transmission in E. coli long-term carriers, potentially leading to revised 
recommendations regulating work re-admittance of carriers of STEC O104:H4 
and other pathogenic E. coli. 
In conclusion, our results suggest that the prevalence of STEC O104:H4 
long-term carriers is low even in highly affected areas. Although shedding of 
STEC O104:H4 may persist >7 months in some patients, secondary transmissions 
among adult household contacts in the post-diarrheal phase of infection 
appear to be rare events, particularly when long-term carriers are regularly 
followed-up. Therefore, clinicians and public health authorities should be 
aware that extended duration of shedding does occur and that reminders 
about consequent hygiene precautions can help to prevent secondary 
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Figure 1: Follow-up of screening-positive carriers. Time (days) of symptom 
onset before screening, time (days) of stool sampling after screening, and 





Figure: Estimated survival function from 57 cases when taking interval-
censoring into account (Turnbull’s method). For comparison, Kaplan-Meier 
estimated survival curves are given when imputing the event time as 
beginning, mean or end of the intervals, respectively. Note that the figure 
contains no indication of estimation uncertainty. Only cases with available 
information are included. Cross-sectional and prospective cohort study part; 











































Table: Consumption of food items among cases and non-cases and 
association with disease outcome; only participants with available 
information are included. Cross-sectional study part; Shiga-toxin producing E. 
coli O104:H4 outbreak, Germany, 2011.   
Food item Cases, no. (%) Non-cases, no. (%) OR 95% CI p value 
Sprouts 31 (60.8) 10 (6.3) 23.1 9.9-54.1 <0.001 
Cucumber 39 (72.2) 64 (39.5) 4.0 2.0-7.8 <0.001 
Raw tomatoes 46 (78.0) 80 (49.1) 3.7 1.8-7.3 <0.001 
Lettuce 41 (71.9) 73 (46.2) 3.0 1.5-5.8 0.001 
Ground meat (beef) 18 (38.3) 75 (47.5) 0.7 0.4-1.3 0.269 
Unpasteurized milk 
products 11 (20.4) 32 (20) 1 0.5-2.2 0.953 
 
 
 
